Nicotinamide derivatives useful as PDE4 inhibitors

Details Nicotinamide derivatives useful as PDE4 inhibitors Nicotinamide derivatives useful as PDE4 inhibitors

2006-06-06

2006-06-06

Davis, Zinna Northington (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S350000, C546S272700, C546S275400, C546S298000

Reexamination Certificate

active

07056934

ABSTRACT:
This invention relates to nicotinamide derivatives of general formula (I):in which R1, R2and R3have the meanings defined herein, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of such derivatives.

REFERENCES:
patent: 6380218 (2002-04-01), Marfat et al.
patent: 6559168 (2003-05-01), Marfat et al.
patent: 6649633 (2003-11-01), Chambers et al.
patent: 6740655 (2004-05-01), Magee et al.
patent: 2002/0111495 (2002-08-01), Magee et al.
patent: WO9845268 (1998-10-01), None
patent: WO0157025 (2001-08-01), None
patent: WO0157036 (2001-08-01), None
patent: WO0260896 (2002-08-01), None
patent: WO0368235 (2003-08-01), None
Torphy et al., “Phosphodiesterase IV Inhibitors as Therapy for Eosinophil-induced Lung Injury in Asthma”, Environmental Health Perspectives, 1994, 102 Suppl. 10, p. 79-84.
Duplantier et al., “Biarylcarboxylic Acids and -amides: Inhibition of Phosphodiesterase Type IV verses [3H]Rolipram Binding Activity and Their Relationship to Emetic Behavior in the Ferret”, J. Med. Chem., 1996, 39, p. 120-125.
Schneider et al., “Discriminative Stimulus Properties of the Stereoisomers of the Phosphodiesterase Inhibitor Rolipram”, Pharmacology Biochemistry Behavior, 1995, 50, p. 211-217.
Banner and Page, “Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs”, British Journal of Pharmacology, 1995, 114, p. 93-98.
Barnette et al., “The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity”, J. Pharmacol. Exp. Ther., 1995, 273, p. 674-679.
Wright et al., “Differential in vivo and in vitro bronchorelaxant activities of CP-80,633, a selective phosphodiesterase 4 inhibitor”, Can. J. Physiol. Pharmacol., 1997, 75, p. 1001-1008.
Manabe et al., “Anti-inflammantory and bronchodilator properties of KF19514, a phosphodiesterase 4 and 1 inhibitor”, European Journal of Pharmacology, 1997, 332, p. 97-107.
Ukita et al., “Novel Potent, and Selective Phosphodiesterase-4 Inhibitors as Antiasthmatic Agents: Synthesis and Biological Activities of a Series of 1-Pyridylnaphthalene Derivatives”, J. of Med. Chem., 1999, 42, p. 1088-1099.

Affiliated with

Also associated with

Rating

Nicotinamide derivatives useful as PDE4 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nicotinamide derivatives useful as PDE4 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nicotinamide derivatives useful as PDE4 inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3661417